About 2 results found for searched term "Datopotamab" (0.093 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25064 | Datopotamab | Others |
| CDP7657 | ||
| Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan and Datopotamab. | ||
| M40765 | Datopotamab deruxtecan | Antibody-Drug Conjugates (ADCs) |
| Dato-DXd; DS-1062 | ||
| Datopotamab deruxtecan is an antibody-coupled drug (ADC) consisting of a humanized, monoclonal antibody targeting human trophoblast cell surface glycoprotein antigen 2 (Trop2) conjugated to an innovative DNA topoisomerase I inhibitor (DXd) for use in studies related to non-small cell lung cancer (NSCLC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
